Skip to main content
OpenTrials
Recruiting

NCT Number: NCT00478712

Hirschsprung Disease Genetic Study

Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which involves multiple interacting genetic factors.

Recruiting

Interested in participating?

Request Info

Key information

Age range

1 week–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

New York University School of Medicine

New York, 10016, United States

Location status: Recruiting

Location contact

Aravinda Chakravarti, PhD

PRINCIPAL_INVESTIGATOR

Monica Erazo, MS

CONTACT

[email protected]

212-263-8069

About this study

Hirschsprung disease (HSCR) is a birth defect resulting from the absence of nerve (ganglion) cells in the gastrointestinal tract. Hirschsprung disease has a population incidence of 1/5000 live births and most often occurs as an isolated condition. However, approximately 30% of HSCR cases are associated with other birth defects such as Down syndrome, deafness, hypopigmentation, and congenital central hypoventilation syndrome. Hirschsprung disease is a genetic condition with autosomal dominant, autosomal recessive, and multigenic patterns of inheritance described.

Dr. Aravinda Chakravarti's laboratory has been investigating the genetics of Hirschsprung disease (HSCR) for more than twenty five years. The goal of this research study is to identify genes harboring causative HSCR mutations and to better understand the complex inheritance of HSCR in families by whole genome mapping and sequencing studies. Specifically, the study aims to determine the frequency with which mutations in any human gene lead to familial and isolated forms of HSCR. Further, the study will collect clinical information and investigate possible genotype - phenotype correlations.

Molecular analysis using markers and sequencing, and statistical analysis of these data will be used to identify regions of human chromosomes where putative HSCR disease genes may be located. In addition, the DNA sequence of known and/or suspected HSCR genes will be assessed in individual patients and their family members, in search of causative HSCR susceptibility variants and variants that may affect presentation of the disease and treatment outcomes. Phenotypic information will include pathology, surgical, and other clinical outcomes related to Hirschsprung disease. This study will hopefully lead to a better understanding of the genetics of HSCR and, further down the road, improved diagnosis, treatment, and genetic counseling.

This study asks volunteers to:

  • Complete a medical/family history questionnaire
  • Provide access to some medical records
  • Submit blood samples from the individual(s) affected with Hirschsprung disease and his/her parents (if available)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals with Hirschsprung disease and their first degree relatives (any segment length of disease, with or without other congenital anomalies or health problems, single or multiple affected individuals in family)

Exclusion criteria

  • Unable or unwilling to provide sample for genetic studies
  • Individual, parent, or guardian unable to comprehend and provide informed consent

Treatment and study plan

Identification of genetic causes of Hirschsprung Disease

Other

Blood, saliva, or DNA samples are requested from all study participants. The blood or saliva samples are used to isolate DNA in all participants. Blood samples are also used to establish cell lines in some participants.

Primary outcomes

  1. Discovery and characterization of common genetic variation associated with Hirschsprung disease

    Time frame: DNA is isolated up to 1 year after enrollment

    Genome-wide assays of common genetic variation will be assessed using single nucleotide polymorphism (SNP) arrays

  2. Discovery and characterization of copy number variants associated with Hirschsprung disease

    Time frame: DNA is isolated up to 1 year after enrollment

    Copy number variation will be detected using next generation sequencing data and high resolution microarrays that allow for detection of copy number variants across the genome

  3. Discovery and characterization of rare genetic variation associated with Hirschsprung disease

    Time frame: DNA is isolated up to 1 year after enrollment

    Exome sequencing will be used to detect rare variation across all genes in the genome

Secondary outcomes

  1. Correlation of genetic variants with location of transition zone in Hirschsprung disease

    Time frame: Baseline pathology data is obtained up to 1 year after enrollment

    Pathology records and surgical records will be used to determine transition zone

  2. Correlation of genetic variants with risk for enterocolitis in Hirschsprung disease

    Time frame: Baseline clinical data is obtained up to 1 year after enrollment

  3. Characterization of Hirschsprung disease that co-occurs with a known chromosomal disorder

    Time frame: Baseline clinical data is obtained up to 1 year after enrollment

  4. Characterization of Hirschsprung disease that co-occurs with a known single gene syndrome

    Time frame: Baseline clinical data is obtained up to 1 year after enrollment

  5. Characterization of Hirschsprung disease that co-occurs with other congenital anomalies without a known diagnosis

    Time frame: Baseline clinical data is obtained up to 1 year after enrollment

  6. Correlation of genetic variants with need for repeat pull-through surgery in Hirschsprung disease

    Time frame: Baseline clinical data is obtained up to 1 year after enrollment and follow up data is obtained up to 100 years after enrollment

    Assessment of complications that lead to eventual repeat pull-through surgery

  7. Correlation of genetic variants with difficulty controlling stools after pull-through surgery

    Time frame: Baseline clinical data is obtained up to 1 year after enrollment and follow up data is obtained up to 100 years after enrollment

  8. Correlation of genetic variants with chronic constipation after pull-through surgery

    Time frame: Baseline clinical data is obtained up to 1 year after enrollment and follow up data is obtained up to 100 years after enrollment

Study contacts

Contact information is provided by the study sponsor or research team.

Jenna Pucel, MS, CGC

CONTACT

[email protected]

212-263-8069

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Collaborators

  • New York University

Registry information

Official study title

Genetic Analysis of Hirschsprung Disease

Important dates

Study start
2001
Primary completion
2028
Study completion
2028
First posted
May 25, 2007
Registry last updated
Jun 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.